Gyre Therapeutics (GYRE) Price to Sales (2011 - 2026)
Gyre Therapeutics' (GYRE) Price to Sales came in at 5.85 for Q2 2026, down 7.8% from 6.35 a year earlier but up 10.3% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Gyre Therapeutics' Price to Sales stood at 5.53, down 44.0% from FY2024.
- In prior years, Gyre Therapeutics' Price to Sales was 9.87 in FY2024 (-43.1%), 17.34 in FY2023, 0.20 in FY2022 (-95.0%) and 3.90 in FY2021 (-41.5%).
- Quarterly Price to Sales has run from a low of 0.06 in Q1 2023 to a high of 18.61 in Q3 2021 over five years.
- On a year-over-year basis, Price to Sales has declined in each of the last seven quarters, with an average decline of 33.7% over the last seven quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q3 2021, with growth of 270.8%; the weakest was Q2 2023, with a decline of 99.2%.
- According to Business Quant data, Price to Sales for the three prior quarters was 5.30 (Q1 2026), 5.39 (Q4 2025) and 6.15 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.85 |
| Mar 31, 2026 | 5.30 |
| Dec 31, 2025 | 5.39 |
| Sep 30, 2025 | 6.15 |
| Jun 30, 2025 | 6.35 |
| Mar 31, 2025 | 6.72 |
| Dec 31, 2024 | 9.87 |
| Sep 30, 2024 | 10.24 |
| Jun 30, 2024 | 9.15 |
| Mar 31, 2024 | 12.91 |
| Dec 31, 2023 | 17.34 |
| Sep 30, 2023 | 0.10 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | 4.87 |
| Jun 30, 2022 | 10.13 |
| Mar 31, 2022 | 3.12 |
| Dec 31, 2021 | 3.90 |
| Sep 30, 2021 | 18.61 |
API Access
Gyre Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();